Published:
Last updated:
nvt
ID
NL-OMON50398
Source
ToetsingOnline
Brief title
Malaria in travellers to intermediate risk areas
Condition
- Hepatobiliary neoplasms malignant and unspecified
Synonym
malaria tropica
Research involving
Human
Sponsors and support
Primary sponsor
:
GGD Amsterdam
Source(s) of monetary or material Support
:
R&D fonds GGD Amsterdam
Intervention
Keyword
:
compliance, emergency treatment, Malaria, traveller
Outcome measures
Primary outcome
nvt
Secondary outcome
nvt
Background summary
nvt
Study objective
nvt
Study design
nvt
Study burden and risks
nvt
Public
GGD Amsterdam
Nieuwe Achtergracht 100
Amsterdam 1018 WT
NL
Nieuwe Achtergracht 100
Amsterdam 1018 WT
NL
Scientific
GGD Amsterdam
Nieuwe Achtergracht 100
Amsterdam 1018 WT
NL
Nieuwe Achtergracht 100
Amsterdam 1018 WT
NL
Listed location countries
Netherlands
Age
Adults (18-64 years)
Elderly (65 years and older)
Inclusion criteria
Travel to malaria area with intermediate risk, emergency treatment
prescription, 18 years or older, mentally competent, in possession of
smartphone
Exclusion criteria
Travel duration > 13 weeks
Design
Study type
:
Observational invasive
Masking
:
Open (masking not used)
Control
:
Uncontrolled
Primary purpose
:
Prevention
Recruitment
NL
Recruitment status
:
Recruiting
Start date (anticipated)
:
Enrollment
:
1000
Type
:
Actual
Approved WMO
Date
:
Application type
:
First submission
Review commission
:
METC Amsterdam UMC
Approved WMO
Date
:
Application type
:
Amendment
Review commission
:
METC Amsterdam UMC
Approved WMO
Date
:
Application type
:
Amendment
Review commission
:
METC Amsterdam UMC
Approved WMO
Date
:
Application type
:
Amendment
Review commission
:
METC Amsterdam UMC
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL59471.018.17 |